LEXINGTON, Ky. (Aug. 15, 2022) — R. Kip Guy, Ph.D., dean of the University of Kentucky College of Pharmacy (UKCOP), has been named the recipient of the 2022 Philip S. Portoghese Medicinal Chemistry Lectureship Award. This award from the American Chemical Society (ACS) and the Journal of Medicinal Chemistry honors Guy for his outstanding contributions to medicinal chemistry.
“I am humbled and honored to receive this recognition and join the group of medicinal chemistry leaders who have been recognized with the Portoghese Lectureship Award,” said Guy.
The lectureship is named in honor of Phil Portoghese, previous editor-in-chief of the Journal of Medicinal Chemistry. The lectureship is split into Established Investigator and Young Investigator awards to recognize the contributions of two individuals who have significantly impacted medicinal chemistry research. Guy, whose work in medicinal chemistry and drug discovery spans decades of innovative research and organizational leadership, will receive the Established Investigator Award.
“Dr. Guy excels as a world-leading scientist, team leader, academic administrator and mentor,” said Jared Hammill, Ph.D., assistant professor of pharmaceutical sciences at UKCOP. “He has repeatedly made outstanding contributions to the practice of medicinal chemistry and is driving the discovery and development of a novel antimalarial clinical candidate, SJ733, currently in phase II clinical trials.”
Guy focuses on discovering and developing new drugs for neglected diseases. He joined UKCOP in 2016 after chairing the Chemical Biology and Therapeutics department at St. Jude Children’s Research Hospital for 10 years. For the past 20 years, Guy’s group has worked extensively on the early development of antimalarial compounds including being one of the leaders of the shift to using phenotypic methods to identify and develop new classes of antimalarial drugs.
“I believe his most impactful, innovative and paradigm-shifting work came from his efforts employing phenotypic lead discovery and development for rare pediatric cancers and neglected infectious diseases of the developing world, especially Africa,” said Hammill, whose nomination resulted in Guy’s selection as this year’s award recipient. “Engraining in myself and his other trainees not only the principles of physiologically focused medicinal chemistry but also that solving real problems and running complex organizations requires pulling together individuals from different cultures and backgrounds to a common ambition, balancing vision and teamwork, and maintaining alignment of team members to clear goals.”
Guy will present the award lecture at the ACS Fall 2022 meeting in Chicago on Aug. 21.
The University of Kentucky is increasingly the first choice for students, faculty and staff to pursue their passions and their professional goals. In the last two years, Forbes has named UK among the best employers for diversity, and INSIGHT into Diversity recognized us as a Diversity Champion four years running. UK is ranked among the top 30 campuses in the nation for LGBTQ* inclusion and safety. UK has been judged a “Great College to Work for" three years in a row, and UK is among only 22 universities in the country on Forbes' list of "America's Best Employers." We are ranked among the top 10 percent of public institutions for research expenditures — a tangible symbol of our breadth and depth as a university focused on discovery that changes lives and communities. And our patients know and appreciate the fact that UK HealthCare has been named the state’s top hospital for five straight years. Accolades and honors are great. But they are more important for what they represent: the idea that creating a community of belonging and commitment to excellence is how we honor our mission to be not simply the University of Kentucky, but the University for Kentucky.